Arrhythmogenic right ventricular cardiomyopathy
MONDO:0016587Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease that consists in progressive dystrophy of primarily the right ventricular myocardium with fibro-fatty replacement and ventricular dilation, and that is clinically characterized by ventricular arrhythmias and a risk of sudden cardiac death.
Also known as: ARVD, arrhythmogenic RVD, arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic right ventricular dysplasia, right ventricular dysplasia
35 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could supervised exercise be safe for High-Risk heart patients?
Symptom relief Not yet recruitingThis trial investigates whether a structured, moderate-intensity cardiac rehabilitation program is safe for people with arrhythmogenic cardiomyopathy who carry high-risk genetic mutations. Participants will be randomly assigned to either the exercise program or standard physical …
Phase: NA • Sponsor: Juan Jiménez Jáimez • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Heart device data may unlock secrets of rare heart muscle disease
Knowledge-focused Not yet recruitingThis study looks back at the medical records of 300 people with arrhythmogenic cardiomyopathy who have an implantable cardioverter-defibrillator (ICD) and have had dangerous heart rhythms. Researchers want to count how often ICD-related problems occur, such as lead failure or ina…
Sponsor: Policlinico Casilino ASL RMB • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC